FluoSphera
PrivateLast Round
Seed
Jan 12, 2026
Total Funding Raised
$3.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
FluoSphera operates in Healthcare & Life Sciences and is based in Geneva. Its latest recorded funding round was a Seed round in January 2026.
FluoSphera is a biotechnology company that has developed a drug discovery platform of human multi-tissue systems designed to predict clinical drug responses.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FluoSphera Comparables
Compare FluoSphera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quris AI | 80% | |
| Hesperos Inc. | 78% | |
| 28bio | 77% |
For institutional investors. Book with your work email.
FluoSphera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 12, 2026 | ||||
| Grant | Jan 25, 2024 | ||||
| Debt | May 16, 2023 | ||||
| Pre Seed | Mar 1, 2023 | ||||
| Grant | Sep 30, 2021 |
For institutional investors. Book with your work email.
FluoSphera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fongit | Grant, Debt |
| Mountain Labs | Pre Seed |
| Soulmates Ventures | Seed |
| Unitec | Grant |
| EFI Lake Geneva Ventures | Pre Seed |
| IndieBio | Seed, Pre Seed |
| Venture Kick | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
$1.34M raised in Seed funding.
- Jan 12, 2026
Developing AI-based image analysis capabilities using recent funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 28, 2026
FluoSphera SA partners with Sciomics GmbH to launch a joint preclinical profiling service that combines human 3D multi-tissue testing with high-content protein analysis in Switzerland.
- launchesSep 16, 2026
FluoSphera SA and Sciomics launch a joint translational profiling service that combines human-relevant 3D multi-tissue biology with high-content proteomics to assess efficacy, liver-dependent metabolism, organ-specific toxicity, pathways and candidate biomarkers in a single experiment in Switzerland and Germany on Sep 16th '26.
- partners_withSep 7, 2026
FluoSphera SA partners with Leica Microsystems on an integrated workflow combining antibody labeling, 3D human-relevant testing, and light-sheet microscopy for antibody characterization in Switzerland on Sep 7th '26.
- receives_awardSep 7, 2026
FluoSphera SA receives the Top 100 Swiss Startup Award in Switzerland in 2024.
For institutional investors. Book with your work email.
FluoSphera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FluoSphera's valuation, stock price, and market status.
Is FluoSphera a public or private company?
FluoSphera is a private company.
What is the current stock price of FluoSphera?
FluoSphera is a private company, so its shares have no public market price. Caplight tracks FluoSphera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FluoSphera worth (valuation)?
Valuation information for FluoSphera is not publicly available.
Can I buy FluoSphera stock?
FluoSphera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FluoSphera's last funding round?
FluoSphera's most recent funding round was Seed on January 12, 2026.
Who are the main investors in FluoSphera?
Key investors in FluoSphera include Fongit, Soulmates Ventures, Innosuisse.
Will FluoSphera IPO soon?
No public IPO plans have been announced for FluoSphera.
How can I track FluoSphera secondary market activity?
Caplight tracks bids, offers, and trades in FluoSphera's shares on secondary markets.